Evidence map›Paper›PMID 36830099›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Evaluating the Use of Neonatal Colonization Screening for Empiric Antibiotic Therapy of Sepsis and Pneumonia.

Alisa Bär, Sabina Schmitt-Grohé, Jürgen Held, Julia Lubig, Gregor Hanslik, Fabian B Fahlbusch, Heiko Reutter, Joachim Woelfle, Adriana van der Donk, Maria Schleier and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Alisa BärDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Sabina Schmitt-GrohéDivision of Allergology, Pulmonology and Mucoviscidosis, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Jürgen HeldInstitute of Clinical Microbiology, Immunology and Hygiene, University Clinic Erlangen, Wasserturmstraße 3/5, 91054 Erlangen, Germany.ORCID 0000-0003-1130-9727
Julia LubigDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Gregor HanslikDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Fabian B FahlbuschDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Heiko ReutterDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.ORCID 0000-0002-3591-5265
Joachim WoelfleDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.ORCID 0000-0002-9132-6174
Adriana van der DonkDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Maria SchleierDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Tobias HeppInstitute for Medical Informatics, Biometry and Epidemiology (IMBE), Friedrich-Alexander-University Erlangen-Nuernberg, Waldstr. 6, 91054 Erlangen, Germany.
Patrick MorhartDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuernberg, Loschgestraße 15, 91054 Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

Deutsche ForschungsgemeinschaftFriedrich-Alexander-University of Erlangen-Nuernberg within the funding programsOpen Access Publication Funding
6 · The paper itself

Abstract

(1) Background: Since 2013, weekly screening for multidrug-resistant Gram-negative (MDRGN) bacteria has been performed in German neonatal intensive care units (NICU). National guidelines recommend considering these colonization analyses for antibiotic treatment regimens. Our retrospective single center study provides insight into the clinical dichotomy of bacterial colonization and infection rates in neonates. (2) Methods: We analyzed microbiological data of neonates admitted to our tertiary level NICU over nine years. Colonization with MDRGN/

Indexed as

colonizationMDRMDRGNmultidrug-resistant bacteriamultidrug-resistant Gram-negative bacterianeonatal infectionneonatespneumoniascreeningsepsis

Identifiers

PMID36830099
PMCPMC9952289
OpenAlexW4316813281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.